Atlas Trials

Safety and Efficacy of Bexagliflozin Compared to Placebo as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

Clinical trial NCT03259789 · COMPLETED

Trial details

NCT number
NCT03259789
Sponsor
Theracos
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Type2 Diabetes Mellitus
Start date
2017-11-28
Primary completion
2019-01-23
Enrollment
351

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.